Healthtech Investors & VC Firms in United States
2758 firms in this list, with a median first check of $500K. 731 of them lead rounds. Generated from verified public data and updated continuously.
Forepont Capital Partners
New YorkPre-Seed–Series A
24 people
Sandalphon Capital
ChicagoPre-Seed–Series A$100K – $2M
3 people
The March Group
DavisPre-Seed–Seed
24 people
Whistler Capital Partners
NashvilleGrowth
23 people
Wormhole Capital
Pre-Seed–Growth
2 people
K Street Capital
WashingtonPre-Seed–Growth
7 people
PruVen Capital Partners
Los AltosSeed–Series C$100K – $10M
7 people
Callais Capital Management
New OrleansSeed–Series A
15 people
Pharos Capital Group
DallasGrowth–Late Stage$25M – $50M
21 people
Ingeborg Investments
BentonvilleSeed–Late Stage
5 people
K50 Ventures
EncinitasPre-Seed–Series A$500K – $2M
5 people
Pivotal Life Sciences
San FranciscoPre-Seed–Late Stage
14 people
Union Square Advisors LLC
San Francisco
29 people
WRF Capital
SeattlePre-Seed–Series A$100K – $2M
20 people
Floating Point
BostonPre-Seed–Series B
13 people
Jaws Ventures
Miami BeachSeed–Late Stage
4 people
Eckuity
CypressGrowth
24 people
Breakout Ventures
San FranciscoSeed–Series A$500K – $6M
14 people
SpringTime Ventures
BoulderPre-Seed–Seed$500K – $1M
5 people
Standard Capital
San FranciscoSeries A
8 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Vine Ventures
New YorkPre-Seed–Series A$1M – $10M
10 people
Yamaha Motor Ventures
Palo AltoSeed–Growth$1M – $3M
13 people
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.





































































































